Literature DB >> 25115193

Systematic Review of the Manifestations of Congenital Rubella Syndrome in Infants and Characterization of Disability-Adjusted Life Years (DALYs).

Emily A Simons1,2, Susan E Reef3, Louis Z Cooper4, Laura Zimmerman3, Kimberly M Thompson1,5.   

Abstract

Congenital rubella syndrome (CRS) continues to cause disability among unvaccinated populations in countries with no or insufficient rubella vaccine coverage to prevent transmission. We systematically reviewed the literature on birth outcomes associated with CRS to estimate the duration, severity, and frequency of combinations of morbidities. We searched PubMed, the Science Citation Index, and references from relevant articles for studies in English with primary data on the frequency of CRS manifestations for ≥20 cases and identified 65 studies representing 66 study populations that met our inclusion criteria. We abstracted available data on CRS cases with one or more hearing, heart, and/or eye defect following maternal rubella infection during the period of 0-20 weeks since the last menstrual period. We assessed the quality and weight of the available evidence using a modified Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Most of the evidence originates from studies in developed countries of cohorts of infants identified with CRS in the 1960s and 1970s, prior to the development of standardized definitions for CRS and widespread use of vaccine. We developed estimates of undiscounted disability-adjusted life years (DALYs) lost per CRS case for countries of different income levels. The estimates ranged from approximately 19 to 39 for high-income countries assuming optimal treatment and from approximately 29 to 39 DALYs lost per CRS case in low- and lower- middle-income countries assuming minimal treatment, with the lower bound based on 2010 general global burden of disease disability weights and the upper bound based on 1990 age-specific and treatment-specific global burden of disease disability weights. Policymakers and analysts should appreciate the significant burden of disability caused by CRS as they evaluate opportunities to manage rubella.
© 2014 Society for Risk Analysis.

Entities:  

Keywords:  Birth outcomes; congenital rubella syndrome; disability; life expectancy; rubella

Mesh:

Year:  2014        PMID: 25115193     DOI: 10.1111/risa.12263

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  6 in total

1.  Newborn hearing screening programme in Belgium: a consensus recommendation on risk factors.

Authors:  Bénédicte Vos; Christelle Senterre; Raphaël Lagasse; Alain Levêque
Journal:  BMC Pediatr       Date:  2015-10-16       Impact factor: 2.125

2.  Immunolocalization and Distribution of Rubella Antigen in Fatal Congenital Rubella Syndrome.

Authors:  Mihaela Lazar; Ludmila Perelygina; Roosecelis Martines; Patricia Greer; Christopher D Paddock; Gheorghe Peltecu; Emilia Lupulescu; Joseph Icenogle; Sherif R Zaki
Journal:  EBioMedicine       Date:  2015-11-27       Impact factor: 8.143

3.  Preliminary multiplex microarray IgG immunoassay for the diagnosis of toxoplasmosis and rubella.

Authors:  Priscila T Baschirotto; Marco A Krieger; Leonardo Foti
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-06       Impact factor: 2.743

4.  Modeling the economic impact of different vial-opening thresholds for measles-containing vaccines.

Authors:  Patrick T Wedlock; Elizabeth A Mitgang; Assaf P Oron; Brittany L Hagedorn; Jim Leonard; Shawn T Brown; Jennifer Bakal; Sheryl S Siegmund; Bruce Y Lee
Journal:  Vaccine       Date:  2019-03-23       Impact factor: 3.641

5.  Descriptive epidemiology of rubella disease and associated virus strains in Uganda.

Authors:  Phionah Tushabe; Josephine Bwogi; Emily Abernathy; Molly Birungi; James P Eliku; Ronald Seguya; Henry Bukenya; Prossy Namuwulya; Proscovia Kakooza; Suganthi Suppiah; Theopista Kabaliisa; Mayi Tibanagwa; Immaculate Ampaire; Annet Kisakye; Andrew Bakainaga; Charles R Byabamazima; Joseph P Icenogle; Barnabas Bakamutumaho
Journal:  J Med Virol       Date:  2019-10-09       Impact factor: 2.327

6.  Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world.

Authors:  Jaspreet Toor; Susy Echeverria-Londono; Xiang Li; Kaja Abbas; Emily D Carter; Hannah E Clapham; Andrew Clark; Margaret J de Villiers; Kirsten Eilertson; Matthew Ferrari; Ivane Gamkrelidze; Timothy B Hallett; Wes R Hinsley; Daniel Hogan; John H Huber; Michael L Jackson; Kevin Jean; Mark Jit; Andromachi Karachaliou; Petra Klepac; Alicia Kraay; Justin Lessler; Xi Li; Benjamin A Lopman; Tewodaj Mengistu; C Jessica E Metcalf; Sean M Moore; Shevanthi Nayagam; Timos Papadopoulos; T Alex Perkins; Allison Portnoy; Homie Razavi; Devin Razavi-Shearer; Stephen Resch; Colin Sanderson; Steven Sweet; Yvonne Tam; Hira Tanvir; Quan Tran Minh; Caroline L Trotter; Shaun A Truelove; Emilia Vynnycky; Neff Walker; Amy Winter; Kim Woodruff; Neil M Ferguson; Katy Am Gaythorpe
Journal:  Elife       Date:  2021-07-13       Impact factor: 8.140

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.